BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8137875)

  • 1. Antinociceptive effect of lipopolysaccharide from Pantoea agglomerans on streptozotocin-induced diabetic mice.
    Kamei J; Iwamoto Y; Suzuki T; Misawa M; Kasuya Y; Nagase H; Okutomi T; Soma G; Mizuno D
    Eur J Pharmacol; 1994 Jan; 251(1):95-8. PubMed ID: 8137875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effect of L-arginine in diabetic mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1994 Mar; 254(1-2):113-7. PubMed ID: 8206107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinociceptive effect of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Tamura N; Kamei J
    Eur J Pharmacol; 2005 Nov; 524(1-3):75-9. PubMed ID: 16256106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive effect of dihydroetorphine in diabetic mice.
    Kamei J; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Feb; 275(1):109-13. PubMed ID: 7774657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the antinociceptive effects of oxycodone in diabetic mice.
    Nozaki C; Saitoh A; Kamei J
    Eur J Pharmacol; 2006 Mar; 535(1-3):145-51. PubMed ID: 16533506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (-)-TAN-67 in diabetic mice.
    Kamei J; Kawai K; Mizusuna A; Saitoh A; Morita K; Narita M; Tseng LF; Nagase H
    Eur J Pharmacol; 1997 Mar; 322(1):27-30. PubMed ID: 9088866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of diabetes on the antinociceptive effect of (+/-)pentazocine in mice.
    Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1994 Apr; 84(1):105-10. PubMed ID: 8042002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antinociceptive effects of endomorphin-1 and endomorphin-2 in diabetic mice.
    Kamei J; Zushida K; Ohsawa M; Nagase H
    Eur J Pharmacol; 2000 Mar; 391(1-2):91-6. PubMed ID: 10720639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of diabetes on the antinociceptive effect of beta-endorphin.
    Kamei J; Kawashima N; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Brain Res; 1993 Aug; 619(1-2):76-80. PubMed ID: 8374794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of chronic treatment with naltrindole, a selective delta-opioid antagonist, on mu-opioid receptor-mediated antinociception in diabetic mice.
    Kamei J; Kawashima N; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
    Psychopharmacology (Berl); 1993; 113(2):167-71. PubMed ID: 7855177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of diabetes on pinacidil-induced antinociception in mice.
    Zushida K; Onodera K; Kamei J
    Eur J Pharmacol; 2002 Oct; 453(2-3):209-15. PubMed ID: 12398906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of delta 1-opioid receptors in the antinociceptive effects of mexiletine in mice.
    Kamei J; Saitoh A; Kasuya Y
    Neurosci Lett; 1995 Aug; 196(3):169-72. PubMed ID: 7501275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptozotocin-induced diabetes selectively reduces antinociception mediated by mu 1-opioid receptors, but not that mediated by mu 2-opioid receptors.
    Kamei J; Iwamoto Y; Hitosugi H; Misawa M; Nagase H; Kasuya Y
    Neurosci Lett; 1994 Jan; 165(1-2):141-3. PubMed ID: 8015716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice.
    Kamei J; Saitoh A; Ohsawa M; Suzuki T; Misawa M; Nagase H; Kasuya Y
    Eur J Pharmacol; 1995 Mar; 276(1-2):131-5. PubMed ID: 7781682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effects of (+)-matrine in mice.
    Kamei J; Xiao P; Ohsawa M; Kubo H; Higashiyama K; Takahashi H; Li J; Nagase H; Ohmiya S
    Eur J Pharmacol; 1997 Oct; 337(2-3):223-6. PubMed ID: 9430418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of the antinociceptive effect of spinally administered kyotorphin by naltrindole in mice.
    Ochi T; Ohkubo Y; Mutoh S
    Neurosci Lett; 2002 Apr; 322(2):95-8. PubMed ID: 11958852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive effects of the ORL1 receptor agonist nociceptin/orphanin FQ in diabetic mice.
    Kamei J; Ohsawa M; Kashiwazaki T; Nagase H
    Eur J Pharmacol; 1999 Apr; 370(2):109-16. PubMed ID: 10323258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive effect of shakuyakukanzoto, a Kampo medicine, in diabetic mice.
    Omiya Y; Suzuki Y; Yuzurihara M; Murata M; Aburada M; Kase Y; Takeda S
    J Pharmacol Sci; 2005 Dec; 99(4):373-80. PubMed ID: 16314688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential antinociceptive effects induced by intrathecally administered endomorphin-1 and endomorphin-2 in the mouse.
    Sakurada S; Hayashi T; Yuhki M; Orito T; Zadina JE; Kastin AJ; Fujimura T; Murayama K; Sakurada C; Sakurada T; Narita M; Suzuki T; Tan-no K; Tseng LF
    Eur J Pharmacol; 2001 Sep; 427(3):203-10. PubMed ID: 11567650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of spinal delta1-opioid receptors in inhibiting the formalin-induced nociceptive response in diabetic mice.
    Kamei J; Kashiwazaki T; Hitosugi H; Nagase H
    Eur J Pharmacol; 1997 May; 326(1):31-6. PubMed ID: 9178652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.